Toxicity of antiviral nucleoside analogs and the human mitochondrial DNA polymerase
Toxicity of antiviral nucleoside analogs and the human mitochondrial DNA polymerase
复制标题
DOI:
10.1074/jbc.m106743200
复制
发表时间:
2001-11-02
影响因子:
4.8
通讯作者:
Johnson, KA
中科院分区:
文献类型:
--
作者:
Johnson, AA;Ray, AS;Johnson, KA
To examine the role of the mitochondrial polymerase (Pol gamma) in clinically observed toxicity of nucleoside analogs used to treat AIDS, we examined the kinetics of incorporation catalyzed by Pol gamma for each Food and Drug Administration-approved analog plus 1-(2-deoxy2-fluoro-beta -D-arabinofuranosyl)-5-iodouracil (FIAU), beta -L-(-)-2',3'-dideoxy-3'-thiacytidine (-)3TC, and (R)-9-(2-phosphonylmethoxypropyl) adenine (PMPA). We used recombinant exonuclease-deficient (E200A), reconstituted human Poly holoenzyme in single turnover kinetic studies to measure K-d (K-m) and k(pol) (k(cat)) to estimate the specificity constant (k(cat)/K-m) for each nucleoside analog triphosphate. The specificity constants vary more than 500,000-fold for the series ddC > ddA (ddI) much greater than 2',3'-didehydro-2',3'-dideoxythymidine (d4T) much greater than (+)3TC (-)3TC > PMPA > azidothymidine (AZT) Carbovir (CBV). Abacavir (prodrug of CBV) and PMPA are two new drugs that are expected to be least toxic. Notably, the higher toxicities of d4T, ddC, and ddA arose from their 13-36-fold tighter binding relative to the normal dNTP even though their rates of incorporation were comparable with PMPA and AZT. We also examined the rate of exonuclease removal of each analog after incorporation. The rates varied from 0.06 to 0.0004 s(-1) for the series FIAU > (+)3TC (-)3TC > CBV > AZT > PMPA similar to d4T much greater than ddA (ddI) much greater than ddC. Removal of ddC was too slow to measure (